GL1X · GenesisL1 explorer

Research workbench

Rat neuronal nos heme domain with N-butyl-N'-hydroxyguanidine bound

Analyse Rat neuronal nos heme domain with N-butyl-N'-hydroxyguanidine bound in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1M00
Type
protein
Length
817 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nitric-oxide synthase
EC
1.14.13.39
UniProt
P29476
Ligands
HEM, H4B, BHH, ZN
Pockets
11 · best druggability 0.88

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANitric-oxide synthase (EC 1.14.13.39)protein40741% helix, 15% strandP29476
BNitric-oxide synthase (EC 1.14.13.39)protein41040% helix, 16% strandP29476

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • H4B · 5,6,7,8-tetrahydrobiopterin · ligand · 2 copies · chains A, B
  • BHH · N-butyl-N'-hydroxyguanidine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19100.880.90135HEM, BHH, ACT, H4B
2750.620.9116H4B
31410.470.7727empty
41080.430.7816empty
5570.410.8215empty

Interfaces

1 interface between chains.

  • A–B · 2726 Ų buried · 46 hydrogen bonds · protein-protein

Compared structures

  • 1M00 · Rat neuronal NOS heme domain with N-butyl-N'-hydroxyguanidine bound · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.